Patient Safety Evaluation - March 16, 2021

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence

	5	4	3	2	1
implement the recommendations of the Institute for Safe Medication Practices (ISMP) on safe opioid medication practices.	implement the recommendations of the Institute for Safe Medication Practices (ISMP) on safe opioid medication practices. - 5	implement the recommendations of the Institute for Safe Medication Practices (ISMP) on safe opioid medication practices. - 4	implement the recommendations of the Institute for Safe Medication Practices (ISMP) on safe opioid medication practices. - 3	implement the recommendations of the Institute for Safe Medication Practices (ISMP) on safe opioid medication practices. - 2	implement the recommendations of the Institute for Safe Medication Practices (ISMP) on safe opioid medication practices. - 1

As a result of attending this conference, to what extent do you agree that you will be better able to: (rate the objectives) *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	N/A
Distinguish between a patient who is opioid naïve and one who is opioid tolerant.	Distinguish between a patient who is opioid naïve and one who is opioid tolerant. - 5	Distinguish between a patient who is opioid naïve and one who is opioid tolerant. - 4	Distinguish between a patient who is opioid naïve and one who is opioid tolerant. - 3	Distinguish between a patient who is opioid naïve and one who is opioid tolerant. - 2	Distinguish between a patient who is opioid naïve and one who is opioid tolerant. - 1	Distinguish between a patient who is opioid naïve and one who is opioid tolerant. - N/A
List patient-specific conditions that require a lower starting dose of opioids.	List patient-specific conditions that require a lower starting dose of opioids. - 5	List patient-specific conditions that require a lower starting dose of opioids. - 4	List patient-specific conditions that require a lower starting dose of opioids. - 3	List patient-specific conditions that require a lower starting dose of opioids. - 2	List patient-specific conditions that require a lower starting dose of opioids. - 1	List patient-specific conditions that require a lower starting dose of opioids. - N/A
Discuss the impact of concomitant medication used in combination with opioids.	Discuss the impact of concomitant medication used in combination with opioids. - 5	Discuss the impact of concomitant medication used in combination with opioids. - 4	Discuss the impact of concomitant medication used in combination with opioids. - 3	Discuss the impact of concomitant medication used in combination with opioids. - 2	Discuss the impact of concomitant medication used in combination with opioids. - 1	Discuss the impact of concomitant medication used in combination with opioids. - N/A
Identify strategies used to monitor the effects of opioids.	Identify strategies used to monitor the effects of opioids. - 5	Identify strategies used to monitor the effects of opioids. - 4	Identify strategies used to monitor the effects of opioids. - 3	Identify strategies used to monitor the effects of opioids. - 2	Identify strategies used to monitor the effects of opioids. - 1	Identify strategies used to monitor the effects of opioids. - N/A

How satisfied or dissatisfied were you with the following conference content? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Lecture materials.	Lecture materials. - 5	Lecture materials. - 4	Lecture materials. - 3	Lecture materials. - 2	Lecture materials. - 1
Speaker's effectiveness in addressing the learning objectives.	Speaker's effectiveness in addressing the learning objectives. - 5	Speaker's effectiveness in addressing the learning objectives. - 4	Speaker's effectiveness in addressing the learning objectives. - 3	Speaker's effectiveness in addressing the learning objectives. - 2	Speaker's effectiveness in addressing the learning objectives. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

Name

You are here

Patient Safety Evaluation - March 16, 2021